GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (TSX:DHT.U) » Definitions » Common Stock

DRI Healthcare Trust (TSX:DHT.U) Common Stock : $561.5 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DRI Healthcare Trust Common Stock?

DRI Healthcare Trust's quarterly common stock increased from Sep. 2023 ($518.0 Mil) to Dec. 2023 ($561.5 Mil) but then stayed the same from Dec. 2023 ($561.5 Mil) to Mar. 2024 ($561.5 Mil).

DRI Healthcare Trust's annual common stock declined from Dec. 2021 ($374.0 Mil) to Dec. 2022 ($373.6 Mil) but then increased from Dec. 2022 ($373.6 Mil) to Dec. 2023 ($561.5 Mil).


DRI Healthcare Trust Common Stock Historical Data

The historical data trend for DRI Healthcare Trust's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DRI Healthcare Trust Common Stock Chart

DRI Healthcare Trust Annual Data
Trend Dec21 Dec22 Dec23
Common Stock
374.03 373.58 561.50

DRI Healthcare Trust Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 371.91 371.99 518.05 561.50 561.50

DRI Healthcare Trust Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


DRI Healthcare Trust (TSX:DHT.U) Business Description

Traded in Other Exchanges
Address
100 King Street West, 1 First Canadian Place, Suite 7250, Toronto, ON, CAN, M5X 1B1
DRI Healthcare Trust is a pioneer in global pharmaceutical royalty monetization with a more than 30-year history of accelerating innovation by providing capital to inventors, academic institutions, and biopharma companies. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world.

DRI Healthcare Trust (TSX:DHT.U) Headlines

No Headlines